Herbert Zeh

Chair of Surgery

University of Texas Southwestern Medical Center
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (2)

Pathogen-induced septic death presents a substantial public health challenge, with its neuroimmune mechanisms largely unexplored. Our study investigates neurotransmitter modulation of ACOD1 expression, a regulator of immunometabolism activated by bacterial lipopolysaccharide (LPS). Screening neurotransmitters identifies dopamine as a potent inhibitor of LPS-induced ACOD1 expression in innate immune cells. Mechanistically, DRD2 forms a complex with TLR4, initiating MAPK3-dependent CREB1 phosphorylation and subsequent ACOD1 transcription. Conversely, dopamine disrupts TLR4-MYD88 interaction via DRD2 without affecting the formation of the LPS-induced TLR4-MD2-CD14 complex. Enhanced ACOD1 expression induces CD274/PD-L1 production independently of itaconate, precipitating inflammation-associated immunosuppression in sepsis. Delayed administration of pramipexole, a dopamine agonist, mitigates lethality in bacterial sepsis mouse models. Conversely, the dopamine antagonist aripiprazole exacerbates sepsis mortality. Dysregulation of the dopamine-ACOD1 axis correlates with sepsis severity in patients, indicating a potential therapeutic target for modulating this neuroimmune pathway.

Year:

2025

Purpose: To compare outcomes and molecular characteristics of patients who had surgery after neoadjuvant (NA) chemotherapy, with and without stereotactic ablative radiotherapy (SAbR), for pancreatic cancer. Insight could clarify the benefits of SAbR and provide molecular guidance for future therapeutic regimens. Experimental Design: This single-institution, tertiary care academic center cohort study included all patients diagnosed with pancreatic cancer between 2012 and 2023 treated with NA chemotherapy, with or without SAbR. We compared therapeutic responses, performed patient matching, and conducted Cox modeling to identify differences between groups. We assessed molecular response using RNA sequencing to identify SAbR-induced biologic differences. Results: Among 133 patients receiving chemotherapy and 48 receiving chemotherapy + SAbR, RNA sequencing was available for 29 and 14 patients, respectively. Despite more advanced baseline disease, the SAbR group showed better posttreatment pathology and similar overall survival [HR = 0.97, 95% confidence interval (CI), 0.58–1.60, P = 0.9]. Patient matching indicated that SAbR improved locoregional recurrence-free survival (HR = 0.24, 95% CI, 0.07–0.88, P = 0.009). Arterial involvement raised local failure risk with chemotherapy alone (HR = 3.37, 95% CI, 1.74–6.54, P P = 0.005). Gene set enrichment analysis showed immune activation, with CD8 and NK/NKT cell signatures associated with local control and Treg signatures associated with worse control. Conclusions: NA SAbR is associated with improved pathologic outcomes, enhanced local control, and maintained survival while inducing a distinct immune response. Well-powered studies are needed to clarify its clinical benefits.

Year:

2025

Collaborators (15)

Zhikai Chi

University of Texas Southwestern Medical Center

UNITED STATES
View details

chunhua yu

University of Texas Southwestern Medical Center

UNITED STATES
View details

Cheryl Lewis

Associate Professor

University of Texas Southwestern

UNITED STATES
View details

Todd Aguilera

University of Texas Southwestern Medical Center

UNITED STATES
View details

John Mansour

Professor

University of Texas Southwestern Medical Center

UNITED STATES
View details

Adam Yopp

Professor of Surgery

University of Texas Southwestern Medical Center

UNITED STATES
View details

Ruoxi Zhang

University of Texas Southwestern Medical Center

UNITED STATES
View details

Song Zhang

-

UNITED STATES
View details

Matthew R. Porembka

University of Texas Southwestern Medical Center

UNITED STATES
View details

Ahmed M. Elamir

Assistant professor (tenure track) 

East Carolina University

UNITED STATES
View details

David Hsiehchen

University of Texas Southwestern Medical Center

UNITED STATES
View details

Syed Kazmi

Assistant Professor

University of Texas Southwestern Medical Center

UNITED STATES
View details

Patricio M. Polanco

Professor

-

UNITED STATES
View details

Nina N Sanford

University of Texas Southwestern

UNITED STATES
View details

Haichao Wang

Chief, Basic Science Research Program

Feinstein Institute for Medical Research

UNITED STATES
View details